The efficacy of dual lipid-lowering therapy with ezetimibe and statin on plaque volume regression among patients following percutaneous coronary intervention: a meta-analysis
Event:
ESC Congress 2025
Topic:
Secondary Prevention
Session:
Risk factors and prevention (2)
